A Model-Based Illustrative Exploratory Approach to Optimize the Dosing of Peg-IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy

Hézode et al. recently reported the frequent occurrence of anemia and thrombocytopenia in the ANRS-CO20-CUPIC cohort of hepatitis C virus (HCV) cirrhotic experienced patients treated with pegylated-interferon (Peg-IFN), ribavirin (RBV), and telaprevir or boceprevir.1,2 Using frequent measurements of...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:CPT Pharmacometrics Syst Pharmacol
मुख्य लेखकों: Laouénan, C, Guedj, J, Peytavin, G, Nguyen, TH Tram, Lapalus, M, Khelifa-Mouri, F, Boyer, N, Zoulim, F, Serfaty, L, Bronowicki, J-P, Martinot-Peignoux, M, Lada, O, Asselah, T, Dorival, C, Hézode, C, Carrat, F, Nicot, F, Marcellin, P, Mentré, F
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BlackWell Publishing Ltd 2015
विषय:
Commentary
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4369757/
https://ncbi.nlm.nih.gov/pubmed/26225222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/psp4.8
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन